Physician profile
Sandi L Fields
NPI 1326074840
$2,967.35
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $60.05 · 2021: $16.60 · 2022: $181 · 2023: $1,456 · 2024: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,271 · Education: $50.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.79 |
| Education | $50.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.16 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $532.11 | 2019-2024 | Entyvio, Eohilia, Gattex |
| Pfizer INC. | $325.91 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $205.99 | 2019-2024 | Xifaxan, Plenvu |
| Gilead Sciences, INC. | $197.65 | 2019-2023 | |
| Celgene Corporation | $149.44 | 2023 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $111.84 | 2023-2024 | Dupixent |
| Boston Scientific Corporation | $105.19 | 2019 | |
| Phathom Pharmaceuticals, INC. | $86.05 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $80.98 | 2023-2024 | Dificid |
| Celltrion USA INC. | $80.33 | 2023-2024 | Vegzelma, Yuflyma, Zymfentra |
| Braintree Laboratories, INC. | $78.74 | 2019-2023 | Sutab, Suflave |
| Genzyme Corporation | $64.77 | 2023-2024 | |
| Janssen Biotech, INC. | $60.17 | 2022-2024 | Stelara, Simponi, Simponi Aria |
| Intercept Pharmaceuticals, INC. | $47.90 | 2023 | Ocaliva |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $42.03 | 2024 | Omvoh |
| Aimmune Therapeutics, INC. | $41.09 | 2024 | |
| Ironwood Pharmaceuticals, INC | $30.68 | 2020 | |
| Ardelyx, INC. | $24.57 | 2023 | Ibsrela |
| Nestle Healthcare Nutrition INC. | $24.46 | 2022 | |
| Shire North American Group INC | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandi Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.